advanced search
Dr Abdul Basit
Professor of Pharmaceutics

Is this your profile?

About

Abdul Basit, PhD, is a Professor of Pharmaceutics at the UCL School of Pharmacy. He has also founded multiple biotech companies and is internationally recognised for his research. Over a million patients benefit annually from treatments developed in his group.

Dr Basit has published more than 300 peer-reviewed publications, and his group’s research interests are on additive manufacturing of personalised medicines, sex differences in pharmaceutical research, microbiome interaction with drugs and colonic drug delivery.

Contributions

GI/ORAL
INNOVATIONS IN 3D PRINTED PHARMACEUTICALS
Sarah Trenfield, Abdul Basit and Alvaro Goyanes discuss the latest innovations in 3D printed pharmaceuticals.

More contributions

GI/ORAL
OPTICORE™: A FIRST-IN-CLASS COLONIC TARGETING TECHNOLOGY
Felipe Varum, Roberto Bravo and Abdul Basit discuss the use of colonic targeting coating technology OPTICORE™ to deliver APIs in the treatment of ulcerative colitis (UC) patients.
EARLY INSIGHT
PERSONALISING DRUG PRODUCTS USING 3D PRINTING
Sarah Trenfield and Abdul Basit look at the potential applications of 3D-printing technology to create personalised drug therapies in fields such as multiple drug therapy and paediatric/geriatric care and introduce FabRx’s 3D-printing system, which can produce formulations to suit a variety of situations.
GI/ORAL
OPPORTUNITIES & INNOVATIONS IN COLONIC DRUG DELIVERY
Sejal R Ranmal, Vipul Yadav and Abdul W Basit describe recent insights into the physiology of the colon, advantages of targeting drug release to the colon and introduce Phloral®, Intract’s unique system for achieving drug release in the colon successfully and consistently.
Top